| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/25/2007 | US20070021607 Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them |
| 01/25/2007 | US20070021528 Made by polymerizing the acrylic polymer such as polymethyl methacrylate in the presence of an antifungal agent such as bethoxazin, propiconazole, tebuconazoe, 2-n-octyl-4-isothiazolin-3-one, butyl-BIT |
| 01/25/2007 | US20070021512 administering isoproterenol for treating breast cancer, central nervous system cancer, or renal cancer; delaying the development of breast cancer |
| 01/25/2007 | US20070021511 Composition comprising phytosphingosine or a derivative thereof |
| 01/25/2007 | US20070021510 Co-crystal polymorphs of modafinal and an acid (malonic acid, glycolic acid, fumaric acidacid, etc.,); solvates of ethanol, isopropanol etc.; improved water solubility; bioavailabity; stability; narcolepsy, multiple sclerosis; infertility; eating/sleep disorders; Parkingson's disease; muscle disorders |
| 01/25/2007 | US20070021509 Phosphate transport inhibitors |
| 01/25/2007 | US20070021508 Method for treatment of Helicobacter pylori infection and/or an associated disease |
| 01/25/2007 | US20070021507 Aqueous eye drops with accelerated intraocular migration |
| 01/25/2007 | US20070021506 Stress relieving composition |
| 01/25/2007 | US20070021505 Prevention and treatment of ophthalmic complications of diabetes |
| 01/25/2007 | US20070021504 Composition and/or method for preventing onset and/or recurrence of cardiovascular events |
| 01/25/2007 | US20070021503 Ophthalmic fluid |
| 01/25/2007 | US20070021502 Aniline sulfonamide derivatives and their uses |
| 01/25/2007 | US20070021501 Methods of treating epileptogenesis |
| 01/25/2007 | US20070021500 Methods for neuroprotection |
| 01/25/2007 | US20070021499 S-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile; preparation of purified escitalopram free base and its salts using the crystalline base or hydrobromide of escitalopram; antidepressant ; Dissolving free base in diethylether and removing |
| 01/25/2007 | US20070021498 Novel tricyclic spiroderivatives as modulators of chemokine receptor activity |
| 01/25/2007 | US20070021497 Vitamin e compositions |
| 01/25/2007 | US20070021496 Methods and compositions for diagnosing and treating arthritic disorders and regulating bone mass |
| 01/25/2007 | US20070021495 Sulfonamides as selective estrogen receptor |
| 01/25/2007 | US20070021494 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 01/25/2007 | US20070021493 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 01/25/2007 | US20070021492 Sulfamatet benzothiophene derivatives as steroid sulfatase inhibitors |
| 01/25/2007 | US20070021491 Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events |
| 01/25/2007 | US20070021490 useful as synthetic intermediates to synthesize perindopril |
| 01/25/2007 | US20070021489 such as (4-{2-[5-Carbamimidoyl-1-oxo-1,3-dihydro-isoindol-2-yl]-acetyl}-phenoxy)-acetic acid methyl ester, used for inhibiting the binding of fibrinogen to blood platelets, platelet aggregation and for the treatment of thrombotic diseases |
| 01/25/2007 | US20070021488 Method for treating nervous system disorders and conditions |
| 01/25/2007 | US20070021487 To treat diseases of respiratory, urinary and gastrointestinal systems; highly selective; significant potency; (2R,2S)(1 alpha ,5 alpha ,6 alpha )-N-{-[4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butyl]-3-azabicyclo[3.1.0]hex-6-yl-methyl}-2-hydroxy-2-cyclopentyl-2-phenylacetamide |
| 01/25/2007 | US20070021486 E.g., N-[[5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazol-3-yl]methyl]butane-1-sulfonamide and 3-chloro-N-[[5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazol-3-yl]methyl]benzenesulfonamide; cannabinoid receptor antagonists |
| 01/25/2007 | US20070021485 Aryl (or heteroaryl) azolylcarbinols |
| 01/25/2007 | US20070021484 Substituted N-cinnamyl benzamides |
| 01/25/2007 | US20070021483 Amidine derivatives for treating amyloidosis |
| 01/25/2007 | US20070021482 1,5,7-Trisubstituted benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 01/25/2007 | US20070021481 Anti-androgenic N-[ omega -[3-[4-cyano-3-(trifluoromethyl)-phenyl]-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl]alkyl]-substituted pyrrolidines; treatment of prostate cancer, benign prostate hyperplasia, androgenetic alopecia, hirsutism or acne |
| 01/25/2007 | US20070021480 Biologically active compounds obtainable from Sorangium cellulosum |
| 01/25/2007 | US20070021479 Phorboxazole compounds and methods of their preparation |
| 01/25/2007 | US20070021478 Benzothiazolyl derivatives |
| 01/25/2007 | US20070021477 Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 01/25/2007 | US20070021476 Neuroprotectants; treatment of neuropathies resulting from chemtherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases; neurodegenerative diseases; enzyme inhibitors for seine/threonine kinases, phosphatases; Alzheimer' |
| 01/25/2007 | US20070021475 2-(2-chloro-6-fluoro-phenyl)-N-{cis-4-[4-(pyrrolidine-1-carbonyl)-[1,2,3]triazol-1-yl]-cyclohexyl}-acetamide; anxiety, depression, bipolar disorders, Parkinson's disease, schizophrenia and pain. |
| 01/25/2007 | US20070021474 Heterocyclically Substituted Benzoylureas, Process For Their Preparation and Their Use as Pharmaceuticals |
| 01/25/2007 | US20070021473 Novel ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof |
| 01/25/2007 | US20070021472 N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide; potent and highly selective inhibitors; coagulation disorders; antithrombotic agents; diagnostic reagents; good bioavailability and/or solubility |
| 01/25/2007 | US20070021471 Crystalline N-(2-((4-Hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide ethanolates |
| 01/25/2007 | US20070021470 Crystalline N-(2-((4-Hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide methanolates |
| 01/25/2007 | US20070021469 Reacting nicotine with trimethylsilylchloride and lithium in polar aprotic solvent to form 3-(1-methylpyrrolidin-2-yl)-1,4-bis-trimethylsilanyl-1,4-dihydropyridine; chemical intermediates such as to nicotinic acetylcholine receptor modulators |
| 01/25/2007 | US20070021468 reacting succinic acid derivatives with substituted hydrazines in presence of acid scavengers and solvents, to form chemical intermediates for benzoxazinones; cyclization |
| 01/25/2007 | US20070021467 Salts of omeprazole and esomeprazole II |
| 01/25/2007 | US20070021466 CCR2 inhibitors and methods of use thereof |
| 01/25/2007 | US20070021465 antiinflamatory agents such as 3-pyridin-3-yl-5-pyridin-4-yl-4,5-dihydro-1,2-oxazole, that inhibit production and release of certain proinflammatory cytokines such as tumor necrosis factor and high mobility group-1 (HMGB1), a protein that accumulates in serum and mediates delayed lethality |
| 01/25/2007 | US20070021464 Methods and compositions for inhibition of angiogenesis with EM-12 Derivatives |
| 01/25/2007 | US20070021463 such as 1-[1-(1-Benzyl-1H-indole-3-carbonyl)-piperidin-4-yl]-1,3-dihydro-benzoimidazol-2-one, which act as vasopressin V1a receptor antagonists, for the treatment of dysmenorrhea, hypertension, heart failure, nephritis, obsessive compulsive disorder, anxiety and depression |
| 01/25/2007 | US20070021462 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
| 01/25/2007 | US20070021461 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
| 01/25/2007 | US20070021460 5-HT7 antagonists; irritable bowel syndrome; diarrhea, constipation |
| 01/25/2007 | US20070021459 2-(3-Phenyl-5-chloro-1-methyl-1H-pyrazol-4-ylmethylsulphanyl)-N-quinolin-3-ylbenzamide; 2-(3-Phenyl-5-chloro-1-methyl-1H-pyrazol-4-ylmethoxy)-N-naphthalin-2-ylbenzamide; obesity, including obesity of the non-insuline-dependent diabetes patients, sleeping disorders, stroke, nausea and vomiting |
| 01/25/2007 | US20070021458 Selective resonance of bodily agents |
| 01/25/2007 | US20070021457 analgesics, antidiarrheal agents, anticonvulsants, antitussives, anti-addiction; 8-Substituted-2,6-methano-3-benzazocines |
| 01/25/2007 | US20070021456 Aminobenzimidazole derivatives |
| 01/25/2007 | US20070021455 Process for the preparation of finasteride form i |
| 01/25/2007 | US20070021454 Spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's disease |
| 01/25/2007 | US20070021453 acetyl coenzyme A carboxylase inhibitors; to treat various vascular, nervous system, metabolic, genital, digestive system, respiratory, neoplasm and infectious diseases; herbicides; N-{1'-[(4-methoxyquinolin-2-yl)carbonyl]-4-oxospiro[chroman-2,4'-piperidin]-6-yl}acetamide |
| 01/25/2007 | US20070021452 Pyrimidin-4-YL-3, 4-thione compounds and their use in therapy |
| 01/25/2007 | US20070021451 Method for preventing or treating neurologic damage after spinal cord injury |
| 01/25/2007 | US20070021450 Indanylamino uracils and their use as antioxidants and neuroprotectants |
| 01/25/2007 | US20070021449 Pyrimidine derivatives for the prevention of hiv infection |
| 01/25/2007 | US20070021448 Treating an inflammatory disorder or inhibiting respiratory burst in adherent neutrophils with chemical inhibitors of neutrophil activation |
| 01/25/2007 | US20070021447 2-Imino-4-(thio)oxo-5-poly cyclovinylazolines for use as p13 kinase ihibitors |
| 01/25/2007 | US20070021446 2-arylbenzothiazole analogues and uses thereof |
| 01/25/2007 | US20070021445 Pyridopyrimidine protein tyrosine phosphatase inhibitors |
| 01/25/2007 | US20070021444 Valacyclovir polymorphs and a process for the preparation thereof |
| 01/25/2007 | US20070021443 Purine and imidazopyridine derivatives for immunosuppression |
| 01/25/2007 | US20070021442 HIV reverse transcriptase inhibitors |
| 01/25/2007 | US20070021440 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 01/25/2007 | US20070021439 Methods of reducing risk of infection from pathogens with soluble amide and ester pyrazinoylguanidine sodium channel blockers |
| 01/25/2007 | US20070021438 Itraconazole solution |
| 01/25/2007 | US20070021437 Inhibiting the proteolytic activity of cathepsin S; 1-[4-(5-Chloro-1H-indol-3-yl)-piperazine-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma |
| 01/25/2007 | US20070021436 4-(7-chloro-quinazolin-4-yl)-piperidine; use in the synthesis of protein tyrosine kinase inhibitors, particularly inhibitors of FLT3 and/or c-kit and/or TrkB |
| 01/25/2007 | US20070021435 Aminopyrimidines as kinase modulators |
| 01/25/2007 | US20070021434 Non-nucleoside anti-hepacivirus agents and uses thereof |
| 01/25/2007 | US20070021433 Pharmacological chaperones for treating obesity |
| 01/25/2007 | US20070021432 Treatment of mesothelioma |
| 01/25/2007 | US20070021431 Reverse-turn mimetics and method relating thereto |
| 01/25/2007 | US20070021430 Novel crystalline form of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor |
| 01/25/2007 | US20070021429 Condensed n-heterocyclic compounds and their use as crf receptor antagonists |
| 01/25/2007 | US20070021428 2-Substituted phenyl-1,3-dihydropyrazolo(4,3-c)cinnolines, e.g., N-[3-(tert-butyl-methyl-amino)-butyl]-4-(6-fluoro-3-oxo-1,3-dihydro-pyrazolo[4,3-c]cinnolin-2-yl)-benzamide, are CD80 antagonists capable of inhibiting the interactions between CD80 and CD28, used for treating autoimmune diseases |
| 01/25/2007 | US20070021427 Novel tricyclic derivatives and their use |
| 01/25/2007 | US20070021426 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors |
| 01/25/2007 | US20070021425 1-(Phenylmethylaminocarbonyl-),4,7-di(oxo-),6-(4-(hydroxylphenyl),8-(piperidino(1,3-phenylene)methyl)-perhydro(pyrazino(2,1-c)-as-triazine); disorders modulated by Wnt-signaling pathway; anticarcinogenic agents; colorectal cancer; restenosis; polycystic kidney disease; angiogenesis inhibition |
| 01/25/2007 | US20070021424 e.g. 2-(methylamino)-2-oxoethyl {2-[(4-chlorophenyl)-oxy]ethyl}carbamate; fatty acid amide hydrolase inhibitor; cannabinoid and vanilloid receptors blocking agent; analgesic, antiinflammatory, anticarcinogenic, anxiolytic agent, neurodegenerative diseases, antidepressant |
| 01/25/2007 | US20070021423 Dual molecules containing peroxy derivative, the synthesis and therapeutic applications thereof |
| 01/25/2007 | US20070021422 administering prokineticin 1 receptor antagonists such as N-{2-[5-(4-Ethyl-benzyl)-1-(4-methoxy-benzyl)-4,6-dioxo-1,4,5,6-tetrahydro-[1,3,5]triazin-2-ylamino]-ethyl}-guanidine, to treat inflammation in the intestines, irritable bowel syndrome, inflammatory bowel disease or Crohn's disease |
| 01/25/2007 | US20070021421 Measurement of gait dynamics and use of beta-blockers to detect, prognose, prevent and treat amyotrophic lateral sclerosis |
| 01/25/2007 | US20070021420 New derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments |
| 01/25/2007 | US20070021419 2-Aminophenyl-4-phenylpyrimidines as kinase inhibitors |
| 01/25/2007 | US20070021418 Method of inhibiting production of osteopontin |
| 01/25/2007 | US20070021417 Catalytic hydrogenation of R N-(4-morpholinyl-3-fluorophenyl)-2-oxo-5-oxazolidinyl-methyl azide to form the methylamine using a aromatic hydrocarbon or aromatic chlorohydrocarbon solvent; fewer by-products; may be acetylated to prepare linezolid without complicated purification steps |
| 01/25/2007 | US20070021416 Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides |
| 01/25/2007 | US20070021415 Pharmaceutical composition for the prevention or treatment of cerebral oedemas |
| 01/25/2007 | US20070021414 1-'2-(4-Hydroxyphenyl)-2-hydroxyethyl!-piperidin-4-ol compounds as nmda receptor antagonists |